PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study

INTRODUCTION: Peroxisome proliferator-activated receptor-α (PPAR-α) agonists can regulate metabolism and protect the cardiovascular system. This study investigated the effects of PPAR-α agonist fenofibrate on insulin resistance in patients with impaired glucose tolerance (IGT). METHODS: This researc...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaomeng, Gao, Xia, Jia, Yumei, Xu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380508/
https://www.ncbi.nlm.nih.gov/pubmed/28361462
http://dx.doi.org/10.1007/s13300-017-0257-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380508/
https://www.ncbi.nlm.nih.gov/pubmed/28361462
http://dx.doi.org/10.1007/s13300-017-0257-4

Ejemplares similares